Cover Image
市場調查報告書

Medgenics Inc.:產品平台分析

Medgenics Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321952
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Medgenics Inc.:產品平台分析 Medgenics Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月30日 內容資訊: 英文 26 Pages
簡介

Medgenics Inc.為了治療為罕見遺傳疾病、罕見疾病所苦的病患這個明確目的,開發獨家技術平台的生物製藥公司。該公司產品治療範圍尚有腎性貧血,orphan代謝症候群,gi症候群,orphan酵素的替換等。

本報告提供Medgenics Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Medgenics Inc.的基本資料

Medgenics Inc.概要

  • 主要資訊
  • 企業資料

Medgenics Inc.:R&D概要

  • 主要的治療範圍

Medgenics Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Medgenics Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Medgenics Inc.:藥物簡介

  • MDGN-201
  • MDGN-204
  • MDGN-205
  • MDGN-206

Medgenics Inc.:開發平台分析

  • 標的別
  • 各分子類型

Medgenics Inc.:最近的開發平台趨勢

Medgenics Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07644CDB

Summary

Global Markets Direct's, 'Medgenics Inc. - Product Pipeline Review - 2015', provides an overview of the Medgenics Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Medgenics Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Medgenics Inc.'s pipeline products

Reasons to buy

  • Evaluate Medgenics Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Medgenics Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Medgenics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Medgenics Inc. Snapshot
    • Medgenics Inc. Overview
    • Key Information
    • Key Facts
  • Medgenics Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Medgenics Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Medgenics Inc. - Pipeline Products Glance
    • Medgenics Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Medgenics Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Medgenics Inc. - Drug Profiles
    • MDGN-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NFC-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDGN-204
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDGN-205
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDGN-206
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Medgenics Inc. - Pipeline Analysis
    • Medgenics Inc. - Pipeline Products by Target
    • Medgenics Inc. - Pipeline Products by Route of Administration
    • Medgenics Inc. - Pipeline Products by Molecule Type
    • Medgenics Inc. - Pipeline Products by Mechanism of Action
  • Medgenics Inc. - Recent Pipeline Updates
  • Medgenics Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Medgenics Inc., Key Information
  • Medgenics Inc., Key Facts
  • Medgenics Inc. - Pipeline by Indication, 2015
  • Medgenics Inc. - Pipeline by Stage of Development, 2015
  • Medgenics Inc. - Monotherapy Products in Pipeline, 2015
  • Medgenics Inc. - Phase II, 2015
  • Medgenics Inc. - Phase I, 2015
  • Medgenics Inc. - Preclinical, 2015
  • Medgenics Inc. - Pipeline by Target, 2015
  • Medgenics Inc. - Pipeline by Route of Administration, 2015
  • Medgenics Inc. - Pipeline by Molecule Type, 2015
  • Medgenics Inc. - Pipeline Products by Mechanism of Action, 2015
  • Medgenics Inc. - Recent Pipeline Updates, 2015
  • Medgenics Inc., Other Locations
  • Medgenics Inc., Subsidiaries

List of Figures

  • Medgenics Inc. - Pipeline by Top 10 Indication, 2015
  • Medgenics Inc. - Pipeline by Stage of Development, 2015
  • Medgenics Inc. - Monotherapy Products in Pipeline, 2015
  • Medgenics Inc. - Pipeline by Top 10 Target, 2015
  • Medgenics Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Medgenics Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Medgenics Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top